Page last updated: 2024-11-03

pyrimethamine and Leishmaniasis, Mucocutaneous

pyrimethamine has been researched along with Leishmaniasis, Mucocutaneous in 3 studies

Maloprim: contains above 2 cpds

Leishmaniasis, Mucocutaneous: A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NEAL, RA1
Müller, E1
Sturm, G1
Halter, K1
Ruckes, J1

Other Studies

3 other studies available for pyrimethamine and Leishmaniasis, Mucocutaneous

ArticleYear
CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
    Annals of tropical medicine and parasitology, 1964, Volume: 58

    Topics: Amidines; Animals; Antimony; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Dapsone; Deoxyrib

1964
[Protozoan infections of the skin].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1974, Volume: 25, Issue:6

    Topics: Amphotericin B; Antimony; Female; Germany, West; Humans; Leishmania; Leishmaniasis, Mucocutaneous; M

1974
[Observation of a South American skin leishmaniasis in Germany].
    Zeitschrift fur Haut- und Geschlechtskrankheiten, 1967, Apr-01, Volume: 42, Issue:7

    Topics: Adult; Antiprotozoal Agents; Berlin; Chloroquine; Humans; Leishmaniasis, Mucocutaneous; Male; Pyrime

1967